HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marc B Bailie Selected Research

N- (2,6- bis(1- methylethyl)phenyl)- N'- ((1- (4- (dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride

5/2018ATR-101, a selective ACAT1 inhibitor, decreases ACTH-stimulated cortisol concentrations in dogs with naturally occurring Cushing's syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marc B Bailie Research Topics

Disease

1Cardiac Arrhythmias (Arrythmia)
01/2022
1Adrenocortical Carcinoma
05/2018
1Cushing Syndrome
05/2018
1Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal)
05/2018
1Chronic Hepatitis (Chronic Active Hepatitis)
05/2015
1Vomiting
05/2015

Drug/Important Bio-Agent (IBA)

1Biomarkers (Surrogate Marker)IBA
01/2022
1N- (2,6- bis(1- methylethyl)phenyl)- N'- ((1- (4- (dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochlorideIBA
05/2018
1Sterol O-AcyltransferaseIBA
05/2018
1Acyl Coenzyme A (Acyl CoA)IBA
05/2018
1Hydrocortisone (Cortisol)FDA LinkGeneric
05/2018
1Adrenocorticotropic Hormone (ACTH)FDA Link
05/2018
1Therapeutic UsesIBA
05/2015
1CopperIBA
05/2015

Therapy/Procedure

1Oral Administration
05/2015